FDA Inspection 804857 — CMP Pharma Inc

CMP Pharma Inc — FEI 1050589

The FDA completed an inspection of CMP Pharma Inc on October 24, 2012 in Farmville, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 24, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Farmville, NC (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
179021 CFR 211.80(b)Handling and Storage to Prevent Contamination
358221 CFR 211.105(a)Identification of containers, lines, equipment
434221 CFR 211.142(b)Storage under appropriate conditions
435221 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
441521 CFR 211.204Returned drug products with doubt cast as to safety et. al.
457621 CFR 211.192No written record of investigation